3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Mycosis Fungoides
4
Lymphoma, T-Cell, Cutaneous
4
Sezary Syndrome
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Carcinoma
2
Thyroid Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Lymphoma, Primary Cutaneous Anaplastic Large Cell
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia
1
Congenital Abnormalities
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Carcinoma In Situ
1
Anemia, Refractory, with Excess of Blasts
1
Aggression
1
Interventions
fluciclovine F-18
2
Positron-Emission Tomography
2
Injections
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
pembrolizumab
1
ioflupane
1
idelalisib
1
aflibercept
1
Water
1
Vertical Dimension
1
Methylene Blue
1
Mammography
1
Drug Delivery Systems
1
Diagnosis, Computer-Assisted
1
Daunorubicin
1
Cytarabine
1
Control Groups
1
CPX-351
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Disease
×
Bexarotene
×
Clear all
No trials found.